APAC Medical Cannabis Market - Industry Trends and Forecast to 2030
- Published Date: 2023-08-18
- Report ID: 145471
- Pages: 250
-
Format:
The Asia-Pacific medical cannabis market is expected to reach USD 13,419.95 million by 2030 from USD 2,696.34 million in 2022, growing at a CAGR of 22.3% during the forecast period of 2023 to 2030.
Market Segmentation
Asia-Pacific Medical Cannabis Market, By Product (Oil, Medical Cannabis Capsules, Patch, Whole Flower, Ground Flower, Vape Pen, Dried Medical Cannabis, Creams & Moisturizer, Masks & Serum, Cleanser, and Others), Source (Natural and Synthetic), Species (Cannabis Indica, Sativa, and Hybrid), Application (Alzheimers Disease, Appetite Loss, Cancer, Inflammatory Bowel Diseases, Eating Disorders, Epilepsy, Autism, Mental Health Conditions, Multiple Sclerosis, Pain Management, Nausea, Muscle Spasms, Wasting Syndrome (Cachexia), Elevate Mood, Depression and Sleep Disorders, Anxiety, and Others), Derivatives (Cannabidiol (CBD), Tetrahydrocannabinol (THC), Delta-8-tetrahydrocannabinol, Cannabinol (CBN), Cannabicyclol (CBL), Cannabichromene (CBC), Cannabigerol (CBG), and Others), Treatment Type (Expectorant, Antiviral, Analgesic, Aphrodisiac, Psychedelic, and Others), Route of Administration (Oral Solutions and Capsules, Smoking, Vaporizers, Topicals, and Others), End User (Pharmaceutical Industry, Research and Development Centers, Homecare Setting, Hospital, Rehab Centers, and Others), Distribution Channel (B2B and B2C), Country (China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, New Zealand, and Rest of Asia-Pacific) Industry Trends and Forecast to 2030
Overview of Asia-Pacific Medical Cannabis Market Dynamics
Driver
Increased medical use of cannabis
Restraint
The complex regulatory structure for the usage of cannabis
Opportunity
Novel product development with increasing R&D activities
Market Players
Some of the major market players operating in the Asia-Pacific medical cannabis market are:
MediPharm Labs Inc.
Tilray
Aurora Cannabis
JAZZ Pharmaceuticals Inc. (GW Pharmaceuticals plc)
HEXO Corp. (Zenabis Global Ltd)
Cresco Labs
Peace Naturals Project Inc.
CANOPY GROWTH CORPORATION
Medical Marijuana, Inc.
Seed Cellar
EcoGen Biosciences
CANNABIS SEEDS USA
Seeds For Me
HUMBOLDT SEED COMPANY
Extractas
World Class Cannabis Seeds (Crop King Seeds)
BARNEY'S FARM
FOLIUM BIOSCIENCES
PharmaHemp
Elixinol Global Limited
ENDOCA
Harmony
MARYS nutritionals, LLC
Pure Ratios
Greenwich Biosciences, Inc.
Upstate Elevator Supply Co.
Apothecanna
BOL Pharma
IDT Australia
TABLE OF CONTENTS
1 INTRODUCTION 156
1.1 OBJECTIVES OF THE STUDY 156
1.2 MARKET DEFINITION 156
1.3 OVERVIEW OF THE ASIA PACIFIC MEDICAL CANNABIS MARKET 156
1.4 LIMITATIONS 158
1.5 MARKETS COVERED 159
2 MARKET SEGMENTATION 168
2.1 MARKETS COVERED 168
2.2 GEOGRAPHICAL SCOPE 169
2.3 YEARS CONSIDERED FOR THE STUDY 170
2.4 CURRENCY AND PRICING 170
2.5 DBMR TRIPOD DATA VALIDATION MODEL 171
2.6 MULTIVARIATE MODELLING 174
2.7 PRODUCT LIFELINE CURVE 174
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 175
2.9 DBMR MARKET POSITION GRID 176
2.10 MARKET APPLICATION COVERAGE GRID 178
2.11 VENDOR SHARE ANALYSIS 179
2.12 SECONDARY SOURCES 180
2.13 ASSUMPTIONS 180
3 EXECUTIVE SUMMARY 181
4 PREMIUM INSIGHTS 184
4.1 PESTEL ANALYSIS 185
4.2 PORTERS FIVE FORCES 186
5 INDUSTRY INSIGHTS 187
5.1 INDUSTRY INSIGHTS PATENT ANALYSIS 187
5.2 DRUG TREATMENT RATE BY MATURED MARKETS 194
5.3 DEMOGRAPHIC TRENDS: IMPACTS ON ALL INCIDENCE RATES 195
5.4 PATIENT FLOW DIAGRAM 196
5.5 KEY PRICING STRATEGIES 197
5.6 KEY PATIENT ENROLLMENT STRATEGIES 198
6 REGULATORY SCENARIO 199
6.1 AUSTRALIA 199
6.2 THAILAND 199
6.3 JAPAN 199
6.4 CHINA 199
6.5 NEW ZEALAND 200
6.6 SINGAPORE 200
6.7 INDIA 200
6.8 MALAYSIA 200
6.9 PHILIPPINES 200
7 MARKET OVERVIEW 201
7.1 DRIVERS 202
7.1.1 INCREASED USE OF CANNABIS IN MEDICINES 202
7.1.2 LEGALIZATION OF CANNABIS 202
7.1.3 STRATEGIC INITIATIVES TAKEN BY KEY PLAYERS 202
7.1.4 RISE IN THE PREVALENCE OF DISEASES THAT REQUIRE THE USE OF CANNABIS 203
7.2 RESTRAINTS 204
7.2.1 COMPLEX REGULATORY STRUCTURE FOR THE USAGE OF CANNABIS 204
7.2.2 ADVERSE EFFECTS DUE TO LONG-TERM USE 204
7.2.3 HIGH-COST PURCHASING AND RUSH FOR PREMIUM QUALITY 205
7.3 OPPORTUNITIES 205
7.3.1 NOVEL PRODUCT DEVELOPMENT WITH INCREASING R&D ACTIVITIES 205
7.3.2 INCREASED ADOPTION OF CANNABIS FOR RECREATIONAL PURPOSES 205
7.3.3 GROWING GERIATRIC POPULATION 206
7.4 CHALLENGES 206
7.4.1 RISE OF THE CANNABIS BLACK MARKET 206
7.4.2 SIDE EFFECTS RELATED TO THE USE OF CANNABIS 207
7.4.3 SHORTAGE OF SKILLED PERSONNEL 207
8 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY PRODUCT 208
8.1 OVERVIEW 209
8.2 OIL 213
8.2.1 OIL, BY TYPE 213
8.2.1.1 CBD OIL CONCENTRATES 213
8.2.1.2 CBD VAPE OIL 214
8.2.1.3 CBD TINCTURES 214
8.2.2 OIL, BY SOURCE 214
8.2.2.1 HEMP BASED 214
8.2.2.2 MARIJUANA BASED 214
8.2.3 OIL, BY SPECIES 214
8.2.3.1 SATIVA 214
8.2.3.2 HYBRID 215
8.2.3.3 CANNABIS INDICA 215
8.2.4 OIL, BY PRODUCT TYPE 215
8.2.4.1 BRANDED 215
8.2.4.1.1 PENGUIN CBD OIL 215
8.2.4.1.2 FAB CBD OIL 216
8.2.4.1.3 GREEN ROADS BROAD SPECTRUM CBD OIL 216
8.2.4.1.4 OTHERS 216
8.2.4.2 GENERIC 216
8.3 DRIED MEDICAL CANNABIS 216
8.3.1 CANNABIS INDICA 217
8.3.2 SATIVA 217
8.3.3 HYBRID 217
8.4 MEDICAL CANNABIS CAPSULES 218
8.4.1 MEDICAL CANNABIS CAPSULES, BY TYPE 218
8.4.1.1 OIL BASED CANNABIS CAPSULES 219
8.4.1.2 POWDER BASED CANNABIS CAPSULES 219
8.4.1.3 LIQUID BASED CANNABIS CAPSULES 219
8.4.1.4 OTHERS 219
8.4.2 MEDICAL CANNABIS CAPSULES, BY CONCENTRATES 219
8.4.2.1 HIGH CBD CAPSULES DIGITAL 219
8.4.2.2 HIGH THC CAPSULE 219
8.4.2.3 THC/CBD BALANCED CAPSULE 220
8.4.2.4 CBD ISOLATE CAPSULE 220
8.4.3 MEDICAL CANNABIS CAPSULES, BY SPECIES 220
8.4.3.1 SATIVA 220
8.4.3.2 CANNABIS INDICA 220
8.4.4 MEDICAL CANNABIS CAPSULES, BY PRODUCT TYPE 220
8.4.4.1 BRANDED 221
8.4.4.1.1 JOY NUTRITION 221
8.4.4.1.2 MEDTERRA ISOLATE CBD GEL CAPSULES 221
8.4.4.1.3 LAZARUS NATURALS 221
8.4.4.1.4 OTHERS 221
8.4.4.2 GENERIC 221
8.5 VAPE PEN 221
8.5.1 VAPE PEN, BY SPECIES 222
8.5.1.1 SATIVA 222
8.5.1.2 HYBRID 222
8.5.1.3 CANNABIS INDICA 223
8.5.2 VAPE PEN, BY PRODUCT TYPE 223
8.5.2.1 BRANDED 223
8.5.2.1.1 KANDYPENS RUBI 223
8.5.2.1.2 SOL E-NECTAR COLLECTOR 223
8.5.2.1.3 PAX ERA PRO-OIL VAPE PEN 224
8.5.2.2 GENERIC 224
8.6 WHOLE FLOWER 224
8.6.1 WHOLE FLOWER, SPECIES 224
8.6.1.1 SATIVA 225
8.6.1.2 HYBRID 225
8.6.1.3 CANNABIS INDICA 225
8.6.2 WHOLE FLOWER, PRODUCT TYPE 225
8.6.2.1 BRANDED 226
8.6.2.1.1 ASTER FARMS 226
8.6.2.1.2 RA FLOWER 226
8.6.2.1.3 BAD APPLE 226
8.6.2.2 GENERIC 226
8.7 CREAMS & MOISTURIZER 227
8.7.1 CREAMS & MOISTURIZER, BY SPECIES 227
8.7.1.1 SATIVA 228
8.7.1.2 HYBRID 228
8.7.1.3 CANNABIS INDICA 228
8.7.2 CREAMS & MOISTURIZER, BY PRODUCT TYPE 228
8.7.2.1 BRANDED 228
8.7.2.1.1 CBDFX MUSCLE & JOINT 229
8.7.2.1.2 ASPEN GREEN MUSCLE RELIEF COOLING CREAM 229
8.7.2.1.3 MEDTERRA PAIN CREAM 229
8.7.2.2 GENERIC 229
8.8 GROUND FLOWER 229
8.8.1 GROUND FLOWER, BY SPECIES 230
8.8.1.1 SATIVA 230
8.8.1.2 HYBRID 230
8.8.1.3 CANNABIS INDICA 230
8.8.2 GROUND FLOWER, BY PRODUCT TYPE 230
8.8.2.1 BRANDED 231
8.8.2.1.1 ASTER FARMS 231
8.8.2.1.2 RA FLOWER 231
8.8.2.1.3 BAD APPLE 231
8.8.2.2 GENERIC 231
8.9 PATCH 232
8.9.1 PATCH, BY TYPE 232
8.9.1.1 RESERVOIR 232
8.9.1.2 LAYER DRUG-IN-ADHESIVE 232
8.9.1.3 OTHERS 233
8.9.2 PATCH, BY SPECIES 233
8.9.2.1 SATIVA 233
8.9.2.2 CANNABIS INDICA 233
8.9.2.3 HYBRID 233
8.9.3 PATCH, BY PRODUCT TYPE 233
8.9.3.1 BRANDED 233
8.9.3.1.1 HEMP BOMBS 234
8.9.3.1.2 PUREKANA 234
8.9.3.1.3 PURE RATIOS 234
8.9.3.1.4 RESERVOIR 234
8.9.3.2 GENERIC 234
8.10 MASKS & SERUM 235
8.10.1 MASKS & SERUM, BY SPECIES 235
8.10.1.1 SATIVA 236
8.10.1.2 CANNABIS INDICA 236
8.10.1.3 HYBRID 236
8.10.2 MASKS & SERUM, BY PRODUCT TYPE 236
8.10.2.1 BRANDED 236
8.10.2.1.1 BUMP & SMOOTH CBD 236
8.10.2.1.2 FACIAL ESSENCE 237
8.10.2.1.3 OTHERS 237
8.10.2.2 GENERIC 237
8.11 CLEANSER 237
8.11.1 CLEANSER, BY SPECIES 237
8.11.1.1 SATIVA 238
8.11.1.2 HYBRID 238
8.11.1.3 CANNABIS INDICA 238
8.11.2 CLEANSER, BY PRODUCT TYPE 238
8.11.2.1 BRANDED 239
8.11.2.1.1 KIEHLS 239
8.11.2.1.2 CBD 101 239
8.11.2.1.3 OTHERS 239
8.11.2.2 GENERIC 239
8.12 OTHERS 240
9 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY SPECIES 241
9.1 OVERVIEW 242
9.2 SATIVA 245
9.3 HYBRID 246
9.4 CANNABIS INDICA 247
10 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY DERIVATIVES 248
10.1 OVERVIEW 249
10.2 CANNABIDIOL (CBD) 252
10.3 TETRAHYDROCANNABINOL (THC)/DELTA-8-TETRAHYDROCANNABINOL 252
10.4 CANNABIGEROL (CBG) 253
10.5 CANNABICHROMENE (CBC) 254
10.6 CANNABINOL (CBN) 255
10.7 CANNABICYCLOL (CBL) 256
10.8 OTHERS 257
11 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY APPLICATION 258
11.1 OVERVIEW 259
11.2 PAIN MANAGEMENT 263
11.2.1 PAIN MANAGEMENT, BY TYPE 263
11.2.1.1 CHRONIC PAIN 263
11.2.1.2 NON-CANCER CHRONIC PAIN 264
11.2.1.3 NEUROLOGICAL PAIN 264
11.2.2 PAIN MANAGEMENT, BY PRODUCT 264
11.2.2.1 OIL 264
11.2.2.2 DRIED MEDICAL CANNABIS 264
11.2.2.3 MEDICAL CANNABIS CAPSULES 264
11.2.2.4 PATCH 265
11.2.2.5 GROUND FLOWER 265
11.2.2.6 CREAMS & MOISTURIZER 265
11.2.2.7 VAPE PEN 265
11.2.2.8 WHOLE FLOWER 265
11.2.2.9 MASKS & SERUM 265
11.2.2.10 CLEANSER 265
11.2.2.11 OTHERS 265
11.3 ANXIETY 265
11.3.1 OIL 266
11.3.2 DRIED MEDICAL CANNABIS 266
11.3.3 MEDICAL CANNABIS CAPSULES 267
11.3.4 PATCH 267
11.3.5 GROUND FLOWER 267
11.3.6 CREAMS & MOISTURIZER 267
11.3.7 VAPE PEN 267
11.3.8 WHOLE FLOWER 267
11.3.9 MASKS & SERUM 267
11.3.10 CLEANSER 267
11.3.11 OTHERS 267
11.4 MUSCLE SPASM 268
11.4.1 OIL 269
11.4.2 DRIED MEDICAL CANNABIS 269
11.4.3 MEDICAL CANNABIS CAPSULES 269
11.4.4 PATCH 269
11.4.5 GROUND FLOWER 269
11.4.6 CREAMS & MOISTURIZER 269
11.4.7 VAPE PEN 270
11.4.8 WHOLE FLOWER 270
11.4.9 MASKS & SERUM 270
11.4.10 CLEANSER 270
11.4.11 OTHERS 270
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
